BioCentury’s BCIQ Deal Charts: Third Quarter 2014 Highlight provides an informative overview of the state of dealmaking in the life sciences industry.
Learn which disease categories exhibited double-digit activity and received triple-digit upfront payments for pharmaceutical product, platform, therapeutic device and diagnostic partnerships. Developed in conjunction with BioCentury Publications, this report features a series of charts that sheds light on life sciences dealmaking for Q3 2014. A quick breakdown is included in each section, which ranges from top M&A buyers to top spenders in partnerships, providing you with a finger on the pulse of dealmaking in the industry.
- Industry partnerships in 2014 compared to the last three years, with additional insight into upfront payments involved in those deals
- 2014 partnerships broken down by disease category with additional insight into upfront payments involved in those deals
- Top spending companies by aggregate value of both upfront payments for partnerships and M&A activity